Myocardial revascularisation in patients with cardiogenic shock.- What do the Guidelines say.

Congress : Acute Cardiovascular Care 2019

• Session : Myocardial revascularisation guidelines tested by reality
• Speaker : U Zeymer (Ludwigshafen,DE)

Treatment of patients with heart failure with reduced ejection fraction (HFrEF) in Germany: differences between cardiologists and primary care physicans

Congress : Heart Failure 2019

• Session : Chronic Heart Failure - Treatment
• Speaker : U Zeymer (Ludwigshafen,DE)

All patients without ST elevation but with troponin elevation after CPR should undergo urgent coronary angiography - CONTRA.

Congress : Acute Cardiovascular Care 2018

• Session : Controversies in patients with NSTEMI
• Speaker : U Zeymer (Ludwigshafen,DE)

Characteristics of heart failure patients treated with Sacubitril - Valsartan in Europe. Results from ARIADNE

Congress : ESC Congress 2018

• Session : Chronic heart failure - Treatment
• Speaker : U Zeymer (Ludwigshafen,DE)

Impact of age > 75 years on one-year events in patients with atrial fibrillation and left atrial appendage occluder implantation. Results of the prospective LAARGE Registry

Congress : ESC Congress 2018

• Session : Atrial fibrillation - Stroke prevention - General
• Speaker : U Zeymer (Ludwigshafen,DE)

Impact of pre-hospital resuscitation on short-and long-term mortality in patients with cardiogenic shock undergoing revascularization. Results of the IABP-SHOCK study.

Congress : ESC Congress 2018

• Session : Cardiogenic shock following myocardial infarction: beyond the mechanics
• Speaker : U Zeymer (Ludwigshafen,DE)

Revascularisation in cardiogenic shock

Congress : ESC Congress 2018

• Session : Management of cardiogenic shock in acute coronary syndromes - The "Shock Team" at work
• Speaker : U Zeymer (Ludwigshafen,DE)

Success rate and clinical outcome of left main PCI in patients with AMI complicated by cardiogenic shock. Results of the ALKK-registry.

Congress : ESC Congress 2018

• Session : Acute coronary syndrome miscellaneous
• Speaker : U Zeymer (Ludwigshafen,DE)

The ACCA-EAPCI registry on ST-elevation myocardial infarction of the European Society of Cardiology (ESC)

Congress : ESC Congress 2018

• Session : ESC/EORP Late Breaking Registry Results
• Speaker : U Zeymer (Ludwigshafen,DE)

What is the optimal timing of administration of P2Y12 inhibitor in STEMI?

Congress : Acute Cardiovascular Care 2018

• Session : Optimisation of STEMI treatment
• Speaker : U Zeymer (Ludwigshafen,DE)

How representive is the PARADIGM heart failure population ?

Congress : ESC Congress 2017

• Session : Acute heart failure (AHF)
• Speaker : U Zeymer (Ludwigshafen,DE)

Inhospital mortality in patients with infarct-relaled cardiogenic shock undergoing coronary angiography treated with and without acute revascularization therapy.

Congress : ESC Congress 2017

• Session : Acute cardiac care
• Speaker : U Zeymer (Ludwigshafen,DE)

Rationale and design of ARIADNE. assessment of real life care describing european heart failure management

Congress : Heart Failure 2017

• Session : Chronic heart failure
• Speaker : U Zeymer (Ludwigshafen,DE)

Indications, procedural success rates and safety of interventional left atrial appendage occlusion in elderly patients (> 75 years) in clinical practice. Results of the prospective LAARGE Registry.

Congress : ESC Congress 2016

• Session : Catheter ablation in atrial fibrillation and other interventions
• Speaker : U Zeymer (Ludwigshafen,DE)

The role of revascularisation.

Congress : Acute Cardiovascular Care 2016

• Session : Cardiogenic shock
• Speaker : U Zeymer (Ludwigshafen,DE)

All patients with STEMI should receive bivalirudin at first medical contact: PRO.

Congress : Acute Cardiovascular Care 2015

• Session : Optimal choice and timing of antithrombotic therapy in ACS
• Speaker : U Zeymer (Ludwigshafen,DE)

High event rate in patients with acute coronary syndromes and atrial fibrillation: Results from the prospective EPICOR Registry

Congress : ESC Congress 2015

• Session : STEMI I
• Speaker : U Zeymer (Ludwigshafen,DE)

High mortality in patients with ST elevations undergoing emergency coronary angiography not treated with primary PCI or CABG.

Congress : ESC Congress 2015

• Session : Acute phase of STEMI
• Speaker : U Zeymer (Ludwigshafen,DE)

Influence of morphine on the effect of clopidogrel and prasugrel in patients with ST elevation myocardial infarction. Results of the ETAMI trial.

Congress : ESC Congress 2015

• Session : Platelets, thrombosis and coagulation
• Speaker : U Zeymer (Ludwigshafen,DE)

PRESERVATION I: bioabsorbable cardiac matrix for the prevention of remodeling of the ventricle after large ST-segment elevation myocardial infarction

Congress : ESC Congress 2015

• Session : Hot Line VI - Coronary artery disease
• Speaker : U Zeymer (Ludwigshafen,DE)

Prognosis and risk prediction.

Congress : Acute Cardiovascular Care 2015

• Session : Update in NSTE-ACS
• Speaker : U Zeymer (Ludwigshafen,DE)

Risk assessment: bleeding versus thrombosis.

Congress : ESC Congress 2015

• Session : Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome
• Speaker : U Zeymer (Ludwigshafen,DE)

Risk prediction of patients with and without acute coronary syndrome.

Congress : Heart Failure 2015

• Session : Cardiogenic shock: how can we improve prognosis?
• Speaker : U Zeymer (Ludwigshafen,DE)

Culprit lesion only PCI or complete revascularisation in patients with multivessel disease.

Congress : ESC Congress 2014

• Session : STEMI complicated by cardiogenic shock
• Speaker : U Zeymer (Ludwigshafen,DE)

Long-term efficacy and safety of prasugrel compared to clopidogrel in patients with acute coronary syndromes in clinical practice. Results of the prospective German CPU registry.

Congress : ESC Congress 2014

• Session : Antiplatelet therapy in acute coronary syndrome patients
• Speaker : U Zeymer (Ludwigshafen,DE)

More rapid platelet inhibition with prehospital administration of 60 mg prasugrel compared to 600 mg clopidogrel in patients with STEMI and primary PCI. The double-blind , randomized ETAMI trial.

Congress : ESC Congress 2014

• Session : Improving outcomes in STEMI
• Speaker : U Zeymer (Ludwigshafen,DE)

Optimal revascularisation: the jury is still out.

Congress : ESC Congress 2014

• Session : Management of cardiogenic shock related to acute coronary syndromes
• Speaker : U Zeymer (Ludwigshafen,DE)

Optimal timing of coronary angiography.

Congress : ESC Congress 2014

• Session : Optimising outcomes after prehospital resuscitation
• Speaker : U Zeymer (Ludwigshafen,DE)

Prospective evaluation of ischemic and bleeding events in patients with PCI and oral anticoagulation and a matched control group. The LASER registry of the WG of Thrombosis of the ESC.

Congress : ESC Congress 2014

• Session : Refining antithrombotic therapy in coronary artery disease
• Speaker : U Zeymer (Ludwigshafen,DE)

Contra.

Congress : ESC Congress 2013

• Session : Every patient with non ST-elevation myocardial infarction should go direct to the cath lab.
• Speaker : U Zeymer (Ludwigshafen,DE)

Contra.

Congress : ESC Congress 2013

• Session : Every patient with non ST-elevation myocardial infarction should go direct to the cath lab.
• Speaker : U Zeymer (Ludwigshafen,DE)

Differences in incidence of hospital admissions for acute coronary syndromes in five Western countries

Congress : ESC Congress 2013

• Session : Infarction acute phase non STEMI
• Speaker : U Zeymer (Ludwigshafen,DE)

GP IIb/IIIa inhibitors improve outcome in patients with primary PCI for STEMI. Results of the prospective ALKK-Registry.

Congress : ESC Congress 2013

• Session : Infarction acute phase STEMI
• Speaker : U Zeymer (Ludwigshafen,DE)

How to track patients who will develop further events.

Congress : ESC Congress 2013

• Session : The future of anti-thrombotic therapy: reducing long term risk in patients with myocardial infarction
• Speaker : U Zeymer (Ludwigshafen,DE)

• Sponsored by MSD

Impact of immediate multivessel intervention on outcome of patients with multivessel disease undergoing primary PCI for cardiogenic shock. Results of the prospective IABP-Shock II trial.

Congress : ESC Congress 2013

• Session : Understanding and treating ST-elevation myocardial infarction
• Speaker : U Zeymer (Ludwigshafen,DE)

Pretreatment with prasugrel is safe and associated with an improvement outcome in patients with NSTE-ACS

Congress : ESC Congress 2013

• Session : Thrombosis and antithrombotic therapy
• Speaker : U Zeymer (Ludwigshafen,DE)

Quality indicators for acute coronary angioplasty: is it feasible?

Congress : ESC Congress 2013

• Session : Quality indicators for acute cardiac care
• Speaker : U Zeymer (Ludwigshafen,DE)